https://biotechmorning.com/news/lilly-zepbound-single-dose-vials-price-war Biotech Morning en 2026-09-19T14:14:44.868Z Lilly's $449 Bet to Win the Obesity Drug Price War https://biotechmorning.com/news/anthropic-wet-biology-lab Biotech Morning en 2026-09-19T14:13:57.222Z The AI Giant That Just Built a Biology Lab https://biotechmorning.com/news/esr1-mutation-breast-cancer-fda-approval-imlunestrant Biotech Morning en 2026-09-19T14:13:10.581Z The Breast Cancer Mutation That Finally Has a Bullseye on It https://biotechmorning.com/news/intellia-crispr-hae-one-shot-phase-3 Biotech Morning en 2026-09-19T14:12:24.431Z One Shot to Silence a Disease: Intellia's CRISPR Bet Just Paid Off https://biotechmorning.com/news/uk-250-million-life-sciences-investment Biotech Morning en 2026-09-19T14:11:37.702Z The UK Just Bet £250 Million That It Can Out-Science Everyone https://biotechmorning.com/news/cannabis-compound-doubled-semaglutide-weight-loss Biotech Morning en 2026-09-19T14:10:53.158Z The Cannabis Compound That Made Semaglutide Twice as Powerful https://biotechmorning.com/news/us-china-pharma-licensing-deal-restrictions-easing Biotech Morning en 2026-09-19T14:10:05.182Z The U.S. Almost Walled Off China's Drug Pipeline. Now It's Opening the Gate. https://biotechmorning.com/news/curium-lantheus-8-billion-radiopharmaceutical-deal-2 Biotech Morning en 2026-09-19T14:09:19.500Z Radioactive Gold: The $8 Billion Bet That Nuclear Medicine Is Biotech's Next Frontier https://biotechmorning.com/news/electra-therapeutics-350m-ipo-sirp-antibody Biotech Morning en 2026-09-18T14:19:38.796Z The $350M Bet on a Protein Most People Have Never Heard Of https://biotechmorning.com/news/xenon-depression-drug-psychosis-pause Biotech Morning en 2026-09-18T14:18:48.614Z Xenon's Depression Drug Just Triggered the One Side Effect You Never Want to See https://biotechmorning.com/news/fayuvi-gene-therapy-sanfilippo-syndrome-approval Biotech Morning en 2026-09-18T14:18:04.725Z The $3.95 Million Shot That Could Save a Child's Brain https://biotechmorning.com/news/genentech-190m-hanmi-preclinical-obesity-deal Biotech Morning en 2026-09-18T14:17:18.806Z Genentech Just Paid $190M for a Drug That's Never Been in a Human https://biotechmorning.com/news/novo-nordisk-orbis-medicines-oral-macrocycle-deal Biotech Morning en 2026-09-18T14:16:30.813Z Novo Nordisk Just Paid $1.4B for a Chemistry Trick Most Pharma Gave Up On https://biotechmorning.com/news/enhertu-nhs-england-approval-breast-cancer Biotech Morning en 2026-09-18T14:15:39.760Z The Cancer Drug England Couldn't Afford Just Got a Second Chance https://biotechmorning.com/news/315m-preclinical-parkinsons-deal-sk-biopharmaceuticals Biotech Morning en 2026-09-18T14:14:57.234Z $315M for a Drug That Doesn't Exist Yet https://biotechmorning.com/news/novartis-als-trial-failure-lifonebart Biotech Morning en 2026-09-18T14:14:06.673Z ALS Just Broke Another Heart. This Time It Was Novartis. https://biotechmorning.com/news/bms-orum-dac-phase-1-termination Biotech Morning en 2026-09-18T14:13:18.205Z BMS Just Torched $100M on a Drug That Never Made It Past Phase 1 https://biotechmorning.com/news/trutakna-origin-3-kidney-disease-zero-progression Biotech Morning en 2026-09-18T14:12:34.668Z Zero Patients Progressed. This Kidney Drug's Numbers Are Almost Too Good.